Carlos Martín

With more than 15 years of experience, Carlos provides strategic advice on complex corporate transactions. He regularly acts on domestic and cross-border capital markets deals, including IPOs, rights issues, and debt offerings, and has been recognized by The Legal 500 as a Next Generation Partner in Capital Markets: ECM. His practice also encompasses extensive experience in private and public M&A, guiding clients through high-profile transactions with a focus on delivering practical, business-oriented solutions.

Capital Markets

• Represented JB Capital on the accelerated bookbuild offering (ABB) of Enerside.
• Represented Minor International in its initial public takeover bid and further delisting takeover bid over the Spanish listed company NH Hotel Group, S.A.
• Represented a syndicate of bookrunners led by Banco Santander on the EUR 150 million share capital increase of Obrascón Huarte Lain, S. A. (OHLA).
• Represented a syndicate of bookrunners led by Banco Santander and Société Générale on the EUR 156 million accelerated bookbuild offering of Millenium Hospitality Real Estate SOCIMI, S.A.
• Represented All Iron RE SOCIMI in its capital raising process and direct listing on BME Growth.
• Represented Santander and Solventis as bookrunners on the accelerated bookbuild offering (ABB) of Greenalia.
• Represented a syndicate of bookrunners led by JB Capital in the IPO of Aspy on BME Growth.
• Represented the Board of Directors of Telepizza in the context of the public takeover bid launched by KKR.

Private M&A/Investment Rounds

• Represented MHP (Ukraine’s largest agribusiness Group) on the acquisition of UVESA, a Spanish agri-food company with over 1,500 shareholders.
• Represented Pluxee (a listed spin-off from Sodexo) on the acquisition of Cobee.
• Represented Westinghouse on the acquisition of Tecnatom from Iberdrola, Naturgy and Endesa.
• Represented Sanifit Therapeutics and its selling shareholders on the exit process and sale of the company to Vifor Pharma.
• Represented the financial and institutional investors on the exit process and sale of Origo Biopharma to AgomAb Therapeutics.
• Represented a syndicate of investors led by Asabys Partners in the EUR 30 million Series A investment round of Ona Therapeutics.
• Represented Caixa Capital Risk on the sale process of Scutum Logistics (Silence) to Acciona.
• Represented Afterpay on the acquisition of the Spanish fintech Pagantis.

• Next Generation Partner, Capital Markets: Equity, Legal 500 (2025)
• Up and Coming, Capital Markets: Equity, Chambers and Partners Europe (2025)